Gene · 8742
Papers2,943
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,943
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NLRC5-Mediated Epigenetic and Proteomic Regulation of Microglial Panoptosis Drives Neuroinflammation in Multiple Sclerosis. | Mol Neurobiol | 2025 | 41313522 | PubTator, text mining | PubMed |
| Transforming growth factor alpha promotes bullous pemphigoid pathogenesis by disrupting cell adhesion and inducing inflammation. | Cell Mol Life Sci | 2025 | 41307670 | PubTator, text mining | PubMed |
| Recreational Exercise and Inflammatory Patterns in Hashimoto's Thyroiditis: Observations from a Cross-Sectional Study. | Biomolecules | 2025 | 41301428 | PubTator, text mining | PubMed |
| Micropatterning and Nanodropletting of Titanium by Shifted Surface Laser Texturing Significantly Enhances In Vitro Osteogenesis of Healthy and Osteoporotic Mesenchymal Stromal Cells. | J Funct Biomater | 2025 | 41295056 | PubTator, text mining | PubMed |
| Decoding colorectal cancer chemotherapy and immunotherapy resistance: revealing the role of NOL3 using single-cell RNA sequencing and machine learning. | Clin Exp Med | 2025 | 41286470 | PubTator, text mining | PubMed |
| Development of a PANoptosis-Related Pathomics Prognostic Model in Ovarian Cancer: A Multi-Omics Study. | J Cell Mol Med | 2025 | 41284376 | PubTator, text mining | PubMed |
| Biomarkers in Lupus Nephritis: An Evidence-Based Comprehensive Review. | Life (Basel) | 2025 | 41157170 | PubTator, text mining | PubMed |
| Breaking the cycle: immune complexes, complement activation, and novel immunotherapies in lupus nephritis. | Front Immunol | 2025 | 41142829 | PubTator, text mining | PubMed |
| Could Low Serum TWEAK Levels Serve as a Biomarker for Children and Adolescents Diagnosed with ADHD, Specifically the Predominantly Inattentive Subtype? | Clin Psychopharmacol Neurosci | 2025 | 41139599 | PubTator, text mining | PubMed |
| Targeting TWEAK/Fn14 pathway: Implications for stem cell regulation and advancements in skin disease therapies. | Int Immunopharmacol | 2025 | 41138306 | PubTator, text mining | PubMed |
| Association of psychosocial stress and poverty with plasma and extracellular vesicle mitochondrial DNA levels. | Psychoneuroendocrinology | 2025 | 41056622 | PubTator, text mining | PubMed |
| Systemic increase of AMPA receptors associated with cognitive impairment of long COVID. | Brain Commun | 2025 | 41036177 | PubTator, text mining | PubMed |
| Intersecting Transcriptomic Landscapes of Hypertension and Kidney Function in African American Women. | bioRxiv | 2025 | 41030975 | PubTator, text mining | PubMed |
| Detection of Anaphylaxis Through the Cutaneous Barrier. | Curr Allergy Asthma Rep | 2025 | 41016999 | PubTator, text mining | PubMed |
| Unveiling the Causal Roles of the Oral Microbiome-Host Metabolism-Inflammation Axis in Periodontitis: A Mendelian Randomisation Study. | Oral Health Prev Dent | 2025 | 41001956 | PubTator, text mining | PubMed |
| A Systematic Review on the Role of the Stria Vascularis in Menière's Disease Pathogenesis. | J Assoc Res Otolaryngol | 2025 | 40987969 | PubTator, text mining | PubMed |
| Isorhamnetin attenuates renal interstitial fibrosis by targeting TWEAK/Fn14-mediated epithelial-mesenchymal transition. | Front Immunol | 2025 | 40977693 | PubTator, text mining | PubMed |
| Expression and significance of TNFSF12/TWEAK, CD163 in monocytes of patients with newly diagnosed rheumatoid arthritis. | Biomark Med | 2025 | 40964971 | PubTator, text mining | PubMed |
| Low Potassium Triggers Tubular Epithelial NLR Family Pyrin Domain-Containing 3/Apoptosis-Associated Speck-Like Protein-Containing a CARD-Driven Kidney Inflammation Independently of Inflammasomes. | Am J Pathol | 2025 | 40946795 | PubTator, text mining | PubMed |
| Causal Association of Plasma Lipidome With Inflammatory Bowel Diseases and Mediating Role of Circulating Inflammatory Proteins: A Mendelian Randomization Study. | Food Sci Nutr | 2025 | 40937162 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8742/papers?page=7